Morgan Stanley (MS)
NYSEFinancialsCapital MarketsSnapshot 2026-07-07
$222.07-0.01%
Close 2026-07-07 · 1-day change
Reading MS? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track MS free→NYSEFinancialsCapital MarketsSnapshot 2026-07-07
Reading MS? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track MS free→Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Investment Banking & Brokerage is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
The reason to own it still holds.
View ThesisRevenue growth is slowing — up about 10% over the past year and decelerating.
View GrowthRanks in the weakest quality tier of its industry — roughly the bottom 27%, softest on free-cash-flow margins.
View QualityManagement screens strong on capital allocation, earnings delivery, margins.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationModerate volatility — typically moves about 1% a day.
View RiskMorgan Stanley's growth in digital asset services and wealth management supports its valuation. Revenue grew 15% year over year, and the last quarter beat expectations. It trades at 20× P/E versus a peer median of 25×. The market expects less growth than what is forecasted. If Morgan Stanley cuts guidance, it could negatively impact the stock. Peer multiples imply a price about 23% below where it trades. This read is provisional.
Trailing returns as of 2026-07-07. MS is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 25 analysts currently covering MS (as of Jul 2026).
Based on 3 Wall Street analysts offering 12-month price targets for MS in the last 4 months.
A consensus fair price across 11 valuation methods, at three horizons. Current price $222.07. As of 2026-07-08. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Investment Banking & Brokerage — fair value, gap to price, and forward P/E.
Price target adjustment indicates positive outlook for MS.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-07-07. EPS is implied from price ÷ P/E. Not investment advice.
Current $222.07
The last 12 months of price, then the range of analyst 12-month targets from today’s $222.07.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Bottom 25% on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Positive outlook on Indian market supports revenue growth.
Advances: Expand share repurchase program
Directly supports share repurchase program expansion.
Advances: Achieve record net revenues
Integration may drive growth in net revenues.
Fed's stance supports growth and revenue objectives.
Target cut may indicate weaker outlook for Ingersoll Rand.
Advances: Expand share repurchase program
Significant buyback supports capital allocation objectives.
Advances: Achieve record net revenues
Approval supports growth in digital asset services.